Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks Xena. It’s good to see you.
Fasten your seat belts.
https://finance.yahoo.com/news/cybin-announces-former-fda-psychiatry-110000057.html
Nearly 5 million shares (31% daily volume) were sold short yesterday. Seems to me we are at or near bottom. But what does it matter anyways. Some folks focus is on the share price. It seems they fail to acknowledge what is unfolding within the company. Why anybody would sell or short is beyond me. Maybe Dr. Missling sees our immediate need for cash. Seems too ironic to raise capital so close to the positive Adult Rett Syndrome data.
Because he has to announce it. Why $21? The price will get it done, probably today so we can move forward. Missling has been an investment banker with an MBA and a Phd in Science. I think he knows what he is doing. The immediate sp pain will be short lived, IMO.
Nearly 17 million shares traded today. Curious how many of them were short sales. I suspect minimum 50%. Could be prime opportunity for a short sqeeze. If Reddit gets involved, this could be interesting, IMO.
Time to give Biogen a push to the side with Anavex 2-73. With little side effects and hopefully, soon to be released efficacy data, the David and Goliath story will not only be front page news but will give real hope for those suffering with Alzheimer’s Disease, IMO.
Australia seems in the forefront of finding medicine that will benefit its people; key word benefits. It seems possible they will push Anavex 2-73 forward to prevent its people from flocking to a drug that may cause brain swelling and bleeding and whose efficacy proved no different than the placebo.
From the Yahoo LYSDY message board:
Biden must be talking about us in Australia. LYSDY is also helping to build the rare earth processing plant in Texas.
https://www.google.com/amp/s/auto.economictimes.indiatimes.com/amp/news/auto-components/biden-looks-abroad-for-electric-vehicle-metals-in-blow-to-u-s-miners/82942009
Cybin establishes Clinical Advisory Board
https://finance.yahoo.com/news/cybin-establishes-clinical-advisory-board-111500926.html
Dr Mauricio Fava
https://www.dfhcc.harvard.edu/insider/member-detail/member/maurizio-fava-md/
Global race for rare earths is intensifying.
https://www.globaltimes.cn/page/202103/1219650.shtml
Cybin at Forefront of Psychedelic Revolution:
https://finance.yahoo.com/news/cybin-inc-neo-cybn-forefront-123000551.html
Surging interest in psychedelic therapeutics:
https://www.networknewswire.com/science-drives-surging-interest-in-psychedelic-therapeutics/
This enterprise seems to be stalled. Hopefully our new Chief Operations Officer will get us moving in the right direction:
https://finance.yahoo.com/news/mindcure-names-tarik-lebbadi-chief-114500310.html
My only other holding in this space is a small position in Mind Cure Health (always in the red). You really loaded the bases with your holdings. I agree, this sector will rule for a while once the word spreads.
All of my DD points me in a positive direction. I’m all in here. Our CEO seems to be doing all the right things. Best of luck to all the early believers here.
https://finance.yahoo.com/news/cybin-progresses-two-psychedelic-investigational-111500144.html
Maybe shorts will soon get hammered:
https://fintel.io/ss/us/avxl
This is not good for the U.S.:
https://www.mining.com/wp-content/uploads/2019/11/us-rare-earths-from-china-reuters.jpg
World Renouned Massachusetts General Hospital Opens New Center:
The center’s mission is to understand how psychedelics enhance the brain’s capacity for change, to optimize current treatments and create new treatments for mental illness and to render the term “treatment resistant” obsolete.
https://www.massgeneral.org/news/hotline/HTL020421/psychedelics#:~:text=Mass%20General%20Launches%20New%20Center%20to%20Study%20Psychedelics,illnesses%2C%20including%20depression%2C%20anxiety%20and%20post-traumatic%20stress%20disorder.
I am confident Cybin will be a major player in this new approach to addressing mental health issues. This appears to be an ideal ground floor opportunity, IMO. Do your own DD.
Thank you, Peter for sharing your in depth knowledge of the science and presenting it in understandable terms.
This may not seem like much to some folks in the investment community, but for me, it shows we have a seasoned CEO that is intent on bringing our company onto one of the larger exchanges where it belongs. Getting off the pinks is always a good thing. Maybe there will be a small bleep on what’s happening in Jamaica as we switch to the upgraded exchange on Monday. Good luck to all.
It seems to be moving in the right direction:
https://finance.yahoo.com/news/1-australias-lynas-beats-profit-220109294.html
Just took a position in LYSDY today. Looks like I may be the only one here for now after those that were here seem to have abandoned ship. But it is a new day and it seems this company’s Rare Earth skills puts them in a position to address this critical need for rare earth materials here in the U.S.
Today’s Presentation:
LYNAS RARE EARTHS 1H21 Results
Investor Presentation
26 February 2021
https://www.lynascorp.com/wp-content/uploads/2021/02/210226-HY21-Investor-Presentation-2182562.pdf
LYNAS RARE EARTHS HALF YEAR 2021 RESULTS
https://www.lynascorp.com/wp-content/uploads/2021/02/210226-Lynas-Releases-HY21-Results-2182561.pdf
Interim Unaudited Consolidated Financial Report For the half year ended 31 December 2020
https://www.lynascorp.com/wp-content/uploads/2021/02/210226-Half-Year-Accounts-2182560.pdf
Awesome conference call. Unlike biib, we are a true science company. If the FDA gives biib approval on June 7 for aducanamab, our Anavex 2-73 could get approval soon after.
Congratulations Longtermbeliever. You have been a great advocate for AVXL.
Pros of investing in individual stocks.
“Potential to beat the market.
Investing in an index fund simply helps you keep pace with the market.
Investing in a successful company that creates new products that transform the way we live, such as Apple and the iPhone, or Facebook with its social network, or Amazon with its online shopping dominance, can make you wildly rich."
(USA Today Mar 23,2020)
“But investing in a successful company that creates new products that transform the way we live, can make you wildly rich."
That seems to be where these new companies are taking us. Just my opinion.
Excellent! Thanks for posting.
Sell the rest of your shares. Then there will be -NO REASON- to post here anymore.
Got these Analyist reports at seeking alpha. The titles of these reports and the dates they were written say it all:
HORST NEEDS TO STEP DOWN IMMEDIATLY. HE HAS CLEARLY DEMONSTRATED HE IS NOT CAPABLE OF BRINGING THIS COMPANY FORWARD, IMO.
The marketplace is screaming for our technology, IMO.
Analysis:
IntelGenx: A Small Cap With A Big Pipeline In Cannabis, Alzheimer's, And ED
Danny Upshaw Wed, Sep. 26, 2018
IntelGenx- Maintaining Buy Rating
Singular Research Thu, Nov. 12, 2015
This Small Cap Is Poised To Tap Multi-Billion Dollar Migraine Treatment Market
Tedra DeSue Thu, Oct. 16, 2014
Intelgenx Leadership Change And CRL Response: Why I'm Still Bullish
Alexander Maxwell Mon, Aug. 04, 2014
IntelGenx: A Compelling Investment Opportunity
Alexander Maxwell Fri, Jun. 27, 2014
The Ducks Are Lining Up For IntelGenx Bulls
Scientist on Stocks Mon, Jan. 27, 2014
IntelGenx Technologies: A Small Cap Company With The Potential For Significant Gains
Alexander Maxwell Sun, Jan. 26, 2014
IntelGenx CEO Provides Insight Into The Company's Catalysts
Ben Yoffe Tue, Feb. 05, 2013
You may have missed what the CEO told us about shutting down advertising efforts until the company could catch up on the backlog the company experienced after the product’s mention several times by Hannity. Since then, the company increased manufacturing capacity and hired more employees. The company initiated a train the trainer program. I feel like I’m waisting my breath. The company is not standing still. They will be offering training to school administrators that will be trained to respond in the event a school shooter shows up. They will be meeting with law enforcement to offer a non lethal means of maintining order. I won’t get into political corruption. It’s there for anyone to see. I don’t have that false sense of security you may have. But as unlikely as it may be, you may be right. Key word, unlikely. Best of luck.
The 2 shorties here: does and kngm, should find another hobby.
Maybe a relationship with one of these companies:
https://thedalesreport.com/life-sciences/psychedelic-stocks-start-the-week-off-at-all-time-highs/
Imagine getting this for Christmas. Be Safe!
https://cdn.shopify.com/s/files/1/0032/4658/7971/files/gift_card_1296x.png?v=1607382405
“ Reverse splits are a sign of good things for companies on the way up, but a sign of bad things for companies on the way down.”
“ Using a reverse split to raise the share price and obtain an uplisting is a very positive sign for a company and is much different than companies that use a reverse split to prevent being delisted. Once again, the confusion relates to delisting as opposed to uplisting. Many people who don't focus on uplistings only encounter reverse splits in the context of companies that are trying to stave off a delisting, so in many people's eyes a reverse split is a sign of a troubled company.”
“ For the relative few of us focused on uplistings, a reverse split is typically the first catalyst that attracts attention to the potential uplisting and is considered a very good event.”
https://www.thestreet.com/opinion/how-an-uplisting-works-10725448